全文获取类型
收费全文 | 201237篇 |
免费 | 46051篇 |
国内免费 | 1183篇 |
专业分类
耳鼻咽喉 | 3302篇 |
儿科学 | 6012篇 |
妇产科学 | 2404篇 |
基础医学 | 35178篇 |
口腔科学 | 7855篇 |
临床医学 | 23812篇 |
内科学 | 44642篇 |
皮肤病学 | 11080篇 |
神经病学 | 23007篇 |
特种医学 | 9468篇 |
外国民族医学 | 2篇 |
外科学 | 29716篇 |
综合类 | 671篇 |
现状与发展 | 3篇 |
一般理论 | 48篇 |
预防医学 | 10937篇 |
眼科学 | 4480篇 |
药学 | 16768篇 |
1篇 | |
中国医学 | 2313篇 |
肿瘤学 | 16772篇 |
出版年
2023年 | 957篇 |
2022年 | 2853篇 |
2021年 | 5722篇 |
2020年 | 6917篇 |
2019年 | 13197篇 |
2018年 | 13224篇 |
2017年 | 13753篇 |
2016年 | 15315篇 |
2015年 | 16672篇 |
2014年 | 17578篇 |
2013年 | 19146篇 |
2012年 | 15274篇 |
2011年 | 14734篇 |
2010年 | 14609篇 |
2009年 | 10302篇 |
2008年 | 9572篇 |
2007年 | 8050篇 |
2006年 | 7412篇 |
2005年 | 6689篇 |
2004年 | 5930篇 |
2003年 | 5266篇 |
2002年 | 4702篇 |
2001年 | 3880篇 |
2000年 | 3549篇 |
1999年 | 2468篇 |
1998年 | 982篇 |
1997年 | 717篇 |
1996年 | 560篇 |
1995年 | 492篇 |
1994年 | 419篇 |
1993年 | 358篇 |
1992年 | 778篇 |
1991年 | 736篇 |
1990年 | 664篇 |
1989年 | 584篇 |
1988年 | 493篇 |
1987年 | 487篇 |
1986年 | 358篇 |
1985年 | 394篇 |
1984年 | 278篇 |
1983年 | 212篇 |
1982年 | 147篇 |
1981年 | 180篇 |
1980年 | 139篇 |
1979年 | 239篇 |
1978年 | 174篇 |
1976年 | 142篇 |
1975年 | 128篇 |
1974年 | 148篇 |
1973年 | 124篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
Abrupt visual loss during anti-vascular endothelial growth factor treatment for type 3 neovascularization 下载免费PDF全文
AIM: To investigate the incidence of abrupt visual loss and its associated factors, during anti-vascular endothelial growth factor (VEGF) treatment for type 3 neovascularization.
METHODS: This retrospective study included 137 eyes that were newly diagnosed with type 3 neovascularization. All eyes were treated with anti-VEGF therapy. Abrupt visual loss was defined as loss of 5 or more lines in best-corrected visual acuity (BCVA) in comparison to the previous visit. The incidence and timing of abrupt visual loss as well as the factors associated with it, were determined. In addition, the BCVA at the final follow-up was compared between the eyes with and those without abrupt visual loss.
RESULTS: The mean follow-up period was 42.4±18.9mo after diagnosis, and abrupt visual loss was noted in 22 eyes (16.1%) at a mean of 19.6±13.9mo. Abrupt visual loss was found to be associated with subretinal hemorrhage in 11 eyes (50.0%), development of or increase in the height of pigment epithelial detachment with fluid in 8 eyes (36.4%), and tears in the retinal pigment epithelium in 3 eyes (13.6%). The logarithm of minimum angle of resolution (logMAR) mean BCVA at the final follow-up was 2.07±0.67 (Snellen equivalents: 20/2349) and 1.00±0.55 (20/200) in eyes with and without abrupt visual loss, respectively. BCVA was significantly worse in the eyes with abrupt visual loss (P<0.001).
CONCLUSION: Abrupt visual loss is noted in 16.1% of patients with type 3 neovascularization and is associated with poor visual outcome. Additional studies are needed to determine how abrupt visual loss can be prevented. 相似文献
994.
995.
L. Kurch D. Hasenclever R. Kluge T. Georgi L. Tchavdarova M. Golombeck O. Sabri A. Eggert W. Brenner K.W. Sykora F.M. Bengel C. Rossig D. Krholz M. Schfers T. Feuchtinger P. Bartenstein R.A. Ammann T. Krause C. Urban R. Aigner S. Gattenlhner W. Klapper C. Mauz‐Krholz 《Pediatric blood & cancer》2019,66(3)
996.
997.
998.
Miriam B. G. Morrell Claudia Alvarez‐Florez Aiqian Zhang Eugenie S. Kleinerman Hannah Savage Enrica Marmonti Minjeong Park Angela Shaw Keri L. Schadler 《Pediatric blood & cancer》2019,66(9)
Recent studies in mouse models of cancer have shown that exercise improves tumor vascular function, thereby improving chemotherapy delivery and efficacy. However, the mechanisms underlying this improvement remain unclear and the effect of exercise on Ewing sarcoma (ES), a pediatric bone and soft tissue cancer, is unknown. The effect of exercise on tumor vascular hyperpermeability, which inversely correlates with drug delivery to the tumor, has also not been evaluated. We hypothesized that exercise improves chemotherapy efficacy by enhancing its delivery through improving tumor vascular permeability. We treated ES‐bearing mice with doxorubicin with or without moderate treadmill exercise. Exercise did not significantly alter ES tumor vessel morphology. However, compared to control mice, tumors of exercised mice had significantly reduced hyperpermeability, significantly decreased hypoxia, and higher doxorubicin penetration. Compared to doxorubicin alone, doxorubicin plus exercise inhibited tumor growth more efficiently. We evaluated endothelial cell sphingosine‐1‐phosphate receptors 1 and 2 (S1PR1 and S1PR2) as potential mediators of the improved vascular permeability and increased function afforded by exercise. Relative to tumors from control mice, vessels in tumors from exercised mice had increased S1PR1 and decreased S1PR2 expression. Our results support a model in which exercise remodels ES vasculature to reduce vessel hyperpermeability, potentially via modulation of S1PR1 and S1PR2, thereby improving doxorubicin delivery and inhibiting tumor growth more than doxorubicin alone does. Our data suggest moderate aerobic exercise should be tested in clinical trials as a potentially useful adjuvant to standard chemotherapy for patients with ES. 相似文献
999.
Anna M. Hood Allison A. King Melanie E. Fields Andria L. Ford Kristin P. Guilliams Monica L. Hulbert Jin‐Moo Lee Desiree A. White 《Pediatric blood & cancer》2019,66(10)
Individuals with sickle cell disease (SCD) experience cognitive deficits; however, it remains unclear whether medical treatments for SCD improve cognition. Given that executive abilities are typically impaired in individuals with SCD, they were the focus of the current study. Our primary hypothesis was that executive abilities would be higher acutely soon after a blood transfusion in children and young adults with SCD. We used tests from the NIH Toolbox to assess executive abilities in 27 participants with SCD receiving chronic transfusion in comparison to 34 participants with SCD receiving hydroxyurea (HU) and 41 non‐SCD demographically matched controls, all of whom were tested at two time points. Participants in the transfusion group completed cognitive testing within 3 days after a transfusion (soon after transfusion) and then within 3 days before their next transfusion (long after transfusion) over an interval of 3‐7 weeks. We found that executive abilities were significantly poorer for the transfusion and HU groups than for the control group. In support of our primary hypothesis, executive abilities for the transfusion group were significantly better soon after a transfusion compared to long after a transfusion, χ2(1) = 17.8, P < .0001. Our results demonstrate that executive abilities were higher acutely following a blood transfusion. These findings have implications for daily functioning, medical decision making, and academic achievement in children and young adults with SCD. 相似文献
1000.